Suppr超能文献

红曲米(紫红曲霉)作为高脂血症替代疗法的安全性和有效性。

Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia.

作者信息

Klimek Matthew, Wang Shan, Ogunkanmi Adeleye

机构信息

Matthew Klimek and Adeleye Ogunkanmi are postdoctoral fellows at Rutgers University Ernest Mario School of Pharmacy in Piscataway, New Jersey. Shan Wang is a clinical pharmacist at Winthrop University Hospital in Mineola, New York.

出版信息

P T. 2009 Jun;34(6):313-27.

Abstract

Red yeast rice is a Chinese fermented rice product (Monascus purpureus) that some have claimed improves blood circulation by decreasing cholesterol and triglyceride levels in humans. The supplement contains naturally occurring monacolin K, the active ingredient found in Merck's prescription agent lovastatin (Mevacor). Lovastatin is associated with various adverse effects such as myopathy and abnormal liver function test results, which can lead to serious problems if patients are not monitored and treated. The inclusion of lovastatin in red yeast rice and the lack of dietary supplement regulation by the FDA raise safety concerns for health care professionals as well as for patients. Studies have shown that red yeast rice products can be beneficial in lowering serum cholesterol levels, but they are not without risk. Furthermore, product uniformity, purity, labeling, and safety cannot be guaranteed.

摘要

红曲米是一种中国发酵米制品(紫红曲霉),一些人声称它可通过降低人体胆固醇和甘油三酯水平来改善血液循环。该补充剂含有天然存在的莫纳可林K,这是默克公司的处方药洛伐他汀(美降脂)中的活性成分。洛伐他汀会引发各种不良反应,如肌病和肝功能检查结果异常,如果不对患者进行监测和治疗,可能会导致严重问题。红曲米中含有洛伐他汀,且美国食品药品监督管理局(FDA)对膳食补充剂缺乏监管,这引发了医疗保健专业人员和患者对其安全性的担忧。研究表明,红曲米产品在降低血清胆固醇水平方面可能有益,但并非没有风险。此外,产品的一致性、纯度、标签和安全性无法得到保证。

相似文献

2
Red Yeast Rice Preparations: Are They Suitable Substitutions for Statins?
Am J Med. 2017 Oct;130(10):1148-1150. doi: 10.1016/j.amjmed.2017.05.013. Epub 2017 Jun 7.
3
Stable isotope ratio analysis for authentication of red yeast rice.
Talanta. 2017 Nov 1;174:228-233. doi: 10.1016/j.talanta.2017.05.057. Epub 2017 May 23.
4
The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders.
Complement Ther Med. 2012 Dec;20(6):466-74. doi: 10.1016/j.ctim.2012.07.004. Epub 2012 Aug 17.
5
In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia.
Appl Microbiol Biotechnol. 2006 May;70(5):533-40. doi: 10.1007/s00253-005-0137-0. Epub 2005 Nov 11.
6
A Randomized Clinical Efficacy Trial of Red Yeast Rice (Monascus pilosus) Against Hyperlipidemia.
Am J Chin Med. 2019;47(2):323-335. doi: 10.1142/S0192415X19500150. Epub 2019 Mar 14.
8
Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.
World J Microbiol Biotechnol. 2016 May;32(5):87. doi: 10.1007/s11274-016-2035-2. Epub 2016 Apr 2.
10
Monascus purpureus for statin and ezetimibe intolerant heterozygous familial hypercholesterolaemia patients: A clinical study.
Atheroscler Suppl. 2017 Nov;30:86-91. doi: 10.1016/j.atherosclerosissup.2017.05.021.

引用本文的文献

1
Red yeast rice with monacolin K for the improvement of hyperlipidemia: A narrative review.
World J Clin Cases. 2025 Sep 26;13(27):105415. doi: 10.12998/wjcc.v13.i27.105415.
2
Treatment of Immune-Mediated Necrotizing Myopathy.
Curr Treatm Opt Rheumatol. 2023 Dec;9(4):168-178. doi: 10.1007/s40674-023-00210-2. Epub 2023 Jul 13.
4
The Anatomical and Physiological Knowledge of the Authors: Why It Matters.
Med Acupunct. 2024 Dec 17;36(6):312-322. doi: 10.1089/acu.2024.0016. eCollection 2024 Dec.
5
Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases.
CEN Case Rep. 2025 Jun;14(3):468-476. doi: 10.1007/s13730-024-00955-2. Epub 2024 Dec 11.
6
Renal Impairment of Proximal Tubular Injury Caused by Red Yeast Rice Supplement: Report of 2 Cases.
Case Rep Nephrol Dial. 2024 Jul 25;14(1):128-137. doi: 10.1159/000540258. eCollection 2024 Jan-Dec.
7
Natural product-based treatment potential for type 2 diabetes mellitus and cardiovascular disease.
World J Diabetes. 2024 Jul 15;15(7):1603-1614. doi: 10.4239/wjd.v15.i7.1603.
8
Decoding the Intricacies of Statin-Associated Muscle Symptoms.
Curr Rheumatol Rep. 2024 Jul;26(7):260-268. doi: 10.1007/s11926-024-01143-y. Epub 2024 Apr 5.
10
Evidence-Based Pharmaceutical Care in Community Pharmacies: A Survey of 595 French Pharmacists.
Pharmacy (Basel). 2023 Oct 7;11(5):161. doi: 10.3390/pharmacy11050161.

本文引用的文献

1
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
Am J Cardiol. 2008 Jun 15;101(12):1689-93. doi: 10.1016/j.amjcard.2008.02.056. Epub 2008 Apr 11.
2
Efficacy and safety of Monascus purpureus Went rice in subjects with secondary hyperlipidemia.
Clin Exp Nephrol. 2008 Jun;12(3):189-94. doi: 10.1007/s10157-008-0033-x. Epub 2008 Mar 26.
5
Symptomatic myopathy due to red yeast rice.
Ann Intern Med. 2006 Sep 19;145(6):474-5. doi: 10.7326/0003-4819-145-6-200609190-00021.
6
Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment.
J Am Geriatr Soc. 2006 Apr;54(4):718-20. doi: 10.1111/j.1532-5415.2006.00668_7.x.
7
Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia.
Eur J Endocrinol. 2005 Nov;153(5):679-86. doi: 10.1530/eje.1.02012.
8
FDA rejects sale of over the counter statins.
BMJ. 2005 Jan 22;330(7484):164. doi: 10.1136/bmj.330.7484.164-d.
9
Chinese red rice-induced myopathy.
South Med J. 2003 Dec;96(12):1265-7. doi: 10.1097/01.SMJ.0000100117.79718.DC.
10
Mycotoxins.
Clin Microbiol Rev. 2003 Jul;16(3):497-516. doi: 10.1128/CMR.16.3.497-516.2003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验